Search for: "Pfizer Inc."
Results 261 - 280
of 1,515
Sort by Relevance
|
Sort by Date
10 Aug 2016, 1:06 pm
Pfizer, Inc. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
27 Jul 2016, 5:06 pm
In Pfizer Canada Inc. v. [read post]
21 Jun 2016, 4:00 am
The Federal Court of Appeal has not squarely addressed the discrete disclosure issue since the SCC arguably “reinvigorated” the debate in Pfizer v Novopharm (“Viagra SCC”)[3], but may address the matter over the next year in Idenix’s pending appeal regarding the hepatitis drug sofosbuvir.[4] There appear to be some inconsistencies in recent FCA decisions. [read post]
16 Jun 2016, 9:59 pm
Today, we review the amici curiae brief submitted by Eli Lilly and Company, Eisai Inc., Upsher-Smith Labroatories, Inc., Pfizer Inc.,... [read post]
6 Jun 2016, 12:21 pm
Shore, Vice President and Chief Ombudsman, CO-OP®, Office of the Ombudsman, Pfizer Inc.; Joan Waters, University Ombuds Officer, Columbia University; James Hurst, Agency Staff Attorney, NYC Department of Consumer Affairs; Nancy Deering, Newark Public Schools and IOAProgram Description: Explore the impact of the ombuds role in advancing conflict resolution and ADR. [read post]
25 May 2016, 3:46 pm
” In In re Pfizer Inc. [read post]
13 May 2016, 10:10 am
Pfizer, Inc., 716 F.3d 1087, 1097 (8th Cir. 2013)). [read post]
2 May 2016, 9:59 pm
Links to each of the filed briefs can be found below: • Brief for Amici Curiae Eli Lilly and Company, Eisai Inc., Upsher-Smith Laboratories, Inc., Pfizer Inc., and Etiometry, Inc. in Support of Petitioner (brief) • Brief of Amicus Curiae by The Chartered Institute... [read post]
28 Apr 2016, 2:39 pm
Pursuant… The post Pharmaceutical Giant Pfizer, Inc. [read post]
28 Apr 2016, 11:09 am
The post Pharmaceutical Giant Pfizer, Inc. [read post]
25 Apr 2016, 12:23 pm
Pfizer, Inc., 2016 WL 1222229 (D. [read post]
23 Apr 2016, 5:58 am
Sleet in Pfizer Inc. v. [read post]
23 Apr 2016, 5:58 am
Sleet in Pfizer Inc. v. [read post]
19 Apr 2016, 7:43 am
Eli Lilly is joined in this brief by Eisai Inc., Upsher-Smith Laboratories, Inc., Pfizer Inc., and Etiometry, Inc. [read post]
15 Apr 2016, 8:26 am
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole magnesium) | prescription drug… [read post]
14 Apr 2016, 4:59 pm
John Fund, Inc. [read post]
6 Apr 2016, 7:37 pm
Pfizer Inc. and Allergan PLC withdrew their planned $160 billion merger, ending what would have been the largest so-called inversion transaction. [read post]
25 Mar 2016, 3:16 pm
Hempstead sued the manufacturer of atorvastatin, Pfizer, Inc. [read post]
24 Mar 2016, 4:00 am
Pfizer Inc. et al., 2016 FC 136, that there was no legal basis to invalidate an issued patent due to non-patent of an administrative fee while the application was pending. [read post]
